The Influence of Premium Income, Claims and Operational Costs on Asset Growth
Internasional Journal of Economic, Agribisnis and Development Studies · 2024
DOI: 10.65142/ijeads.v1i3.69 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internasional Journal of Economic, Agribisnis and Development Studies, 2024. Verfasst von Muhammad Yusra Yusra. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study aims to examine the effect of premium income, claims, and operating expenses on asset growth in conventional insurance companies listed on the Indonesia Stock Exchange (IDX) in 2020 - 2022. The sample in this study is a conventional insurance company listed on the Indonesian Stock Exchange. In withdrawing samples, the authors used saturated sampling techniques, namely sampling techniques when all members of the population are used as samples. The data used is obtained from the Indonesia Stock Exchange publication and the official website of each company. This study uses 17 samples with 3 years of observation so that a total of 51 observations with multiple linear regression estimation of panel data. This research was processed using the Eviews13 program. The results showed that the premium income variable had a positive and significant effect on asset growth, while the claims and operating expenses variables had no significant effect on asset growth
Zitieren
APA
Yusra, M. Y. (2024). The Influence of Premium Income, Claims and Operational Costs on Asset Growth. Internasional Journal of Economic, Agribisnis and Development Studies. https://doi.org/10.65142/ijeads.v1i3.69
Vancouver
Yusra MY. The Influence of Premium Income, Claims and Operational Costs on Asset Growth. Internasional Journal of Economic, Agribisnis and Development Studies. 2024. doi:10.65142/ijeads.v1i3.69
BibTeX
@article{Yusra2024,
author = {Yusra, Muhammad Yusra},
title = {The Influence of Premium Income, Claims and Operational Costs on Asset Growth},
journal = {Internasional Journal of Economic, Agribisnis and Development Studies},
year = {2024},
doi = {10.65142/ijeads.v1i3.69}
}
EUVIMED